Profit Margin (Quarterly) Chart

Historical Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 19.04%
March 31, 2026 16.74%
December 31, 2025 21.22%
September 30, 2025 23.47%
June 30, 2025 15.54%
March 31, 2025 10.17%
December 31, 2024 13.62%
September 30, 2024 13.54%
June 30, 2024 14.29%
March 31, 2024 15.90%
December 31, 2023 24.78%
September 30, 2023 12.38%
June 30, 2023 13.30%
March 31, 2023 6.55%
December 31, 2022 11.26%
September 30, 2022 13.15%
June 30, 2022 7.31%
March 31, 2022 15.47%
December 31, 2021 -0.76%
September 30, 2021 13.43%
June 30, 2021 13.17%
March 31, 2021 11.19%
December 31, 2020 62.44%
September 30, 2020 14.41%
June 30, 2020 10.25%
Date Value
March 31, 2020 4.91%
December 31, 2019 20.03%
September 30, 2019 11.56%
June 30, 2019 -3.12%
March 31, 2019 -9.59%
December 31, 2018 -53.17%
September 30, 2018 17.47%
June 30, 2018 12.45%
March 31, 2018 -13.12%
December 31, 2017 -4.25%
September 30, 2017 -1.08%
June 30, 2017 1.70%
March 31, 2017 -29.30%
December 31, 2016 -4.32%
September 30, 2016 -12.65%
June 30, 2016 -14.71%
March 31, 2016 -16.52%
December 31, 2015 1.15%
September 30, 2015 -40.40%
June 30, 2015 -3.97%
March 31, 2015 -17.72%
December 31, 2014 1.54%
September 30, 2014 -7.54%
June 30, 2014 -10.20%
March 31, 2014 -26.54%

Profit Margin Definition

Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.

Read full definition.

Profit Margin (Quarterly) Range, Past 5 Years

View Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Profit Margin (Quarterly) Benchmarks

View Profit Margin (Quarterly) Benchmarks
Start Trial
Abbott Laboratories 7.37%
Insulet Corp. 11.85%
Baxter International, Inc. 4.56%
Stryker Corp. 19.37%
Becton, Dickinson & Co. 9.05%